Click here to close now.

SYS-CON MEDIA Authors: Ian Goldsmith, Ed Featherston, Elizabeth White, Pat Romanski, Liz McMillan

News Feed Item

Cancer And Chemotherapy Linked With Decreased Risk Of Alzheimer's Disease In Veterans

 

-- Three other studies reported at AAIC 2013 illuminate Alzheimer's risk factors, point to potential new strategies for treatment, prevention

BOSTON, July 15, 2013 /PRNewswire/ -- Most kinds of cancer are associated with a significantly decreased risk of Alzheimer's disease, according to a study of 3.5 million veterans reported today at the Alzheimer's Association International Conference® 2013 (AAIC® 2013) in Boston. In addition, the study suggested that chemotherapy treatment for almost all of those cancers conferred an additional decrease in Alzheimer's risk.

Three other researchers presented results of epidemiologic studies that uncovered risk factors and/or possible therapies for Alzheimer's disease. The results indicated that:

  • Metformin, a medication for type 2 diabetes, may be linked with lower Alzheimer's risk among type 2 diabetes patients compared with other therapies.
  • Older age at retirement appears to be associated with reduced Alzheimer's risk.
  • Socioeconomic disparities may account for the previously observed increased risk of Alzheimer's among African Americans.

"With these large-cohort studies and others, we are beginning to see the outlines of a broad picture of Alzheimer's disease risk and prevention factors," said Maria Carrillo, Ph.D., vice president of medical and scientific relations at the Alzheimer's Association.

"However, we need to know even more about what specific factors actually raise and lower risk for cognitive decline and Alzheimer's. To do that, we need longer-term studies in larger and more diverse populations, and more research funding is required to make that happen. Alzheimer's research would benefit from its own version of the Framingham Study, which has taught us so very much about preventable risk factors for heart disease and stroke," Carrillo said.

"With funding of research being a critical need for progress, the National Plan to Address Alzheimer's Disease must be fully implemented and the $100 million identified for Alzheimer's and dementia research this fiscal year needs to be funded," Carrillo concluded.

Cancer history and chemotherapy are associated with decreased risk of Alzheimer's

A growing body of evidence suggests a possible association of cancer with reduced risk for Alzheimer's disease; until now, whether the association differs between cancer types or is modified by cancer treatment is unknown.

Laura Frain, M.D., a geriatrician at VA Boston Healthcare System, and colleagues analyzed the health records of 3,499,378 veterans age 65 and older who were seen in the VA health care system between 1996 and 2011 and who were free of dementia at baseline. The objective was to evaluate the relationship between a history of 19 different cancers, cancer treatment and subsequent Alzheimer's disease.

Over a median follow-up of 5.65 years, 82,028 veterans were diagnosed with Alzheimer's. Twenty-four (24) percent of those veterans with Alzheimer's had a history of cancer, while 76 percent did not.

The researchers found that most types of cancer were associated with reduced Alzheimer's risk, ranging from 9 percent to 51 percent. Reduced risk was greatest among survivors of liver cancer (51 percent lower risk), cancer of the pancreas (44 percent), cancer of the esophagus (33 percent), myeloma (26 percent), lung cancer (25 percent) and leukemia (23 percent). Cancers that did not confer a reduced Alzheimer's risk, or were associated with an increased risk, included melanoma, prostate and colorectal cancers.

The researchers found no association between cancer history and reduced risk of any other typical age-related health outcome; in fact, cancer was associated with an increased risk of stroke, osteoarthritis, cataracts and macular degeneration. Most cancer survivors were also at increased risk for non-Alzheimer's dementia.

"Together, these findings indicate that the protective relationship between most cancers and Alzheimer's disease is not simply explained by increased mortality among cancer patients," said Frain. "More research is needed to determine if these results have therapeutic implications for Alzheimer's."

Among veterans with a cancer history, treatment with chemotherapy but not radiation reduced Alzheimer's risk by 20 to 45 percent, depending on cancer type, with the exception of prostate cancer.

"The potential protective effect of chemotherapy is supported by recent experimental studies," Frain observed. "The results of this study are interesting because they could help focus future research onto the specific pathways and treatment agents involved in the individual cancers that are associated with a reduced risk of Alzheimer's. This could potentially open new therapeutic strategies for Alzheimer's prevention and treatment."

Metformin is linked with lower dementia risk than other type 2 diabetes therapies

Type 2 diabetes doubles the risk of dementia. However, until recently, little research has been done to examine the association between type 2 diabetes treatments and dementia risk. Rachel Whitmer, Ph.D., and colleagues at Kaiser Permanente Division of Research studied a cohort of 14,891 type 2 diabetes patients age 55 and older who began diabetes therapy between October 1999 and November 2001. Only patients who started a single therapy (metformin, sulfonylureas, thiazolidinediones (TZDs) or insulin) were included. The patients were followed for up to five years.

Patients initiating metformin, an insulin sensitizer, had a significantly reduced risk of developing dementia compared with patients on other diabetes therapies. Compared with those taking sulfonylureas, those initiating metformin had a 20 percent reduced risk of dementia, while those initiating TZD or insulin had no difference in risk.

"These results provide preliminary evidence that the benefits of insulin sensitizers may extend beyond glycemic control to neurocognitive health," said Whitmer. "Research in animals suggests that metformin may contribute to the creation of new brain cells and enhance spatial memory."

Trials are currently under way to evaluate metformin as a potential therapy for dementia and mild cognitive impairment, which is thought to be, in some cases, a precursor to Alzheimer's disease.

Older age at retirement is associated with reduced risk of dementia

Some research has suggested that intellectual stimulation and mental engagement throughout life may be protective against Alzheimer's disease and other dementias. In an analysis of health and insurance records of more than 429,000 self-employed workers in France, reported at AAIC 2013, Carole Dufouil, Ph.D., director of research in neuroepidemiology at INSERM (Institut National de la sante et de la recherche medicale) at the Bordeaux School of Public Health, and colleagues found that retirement at older age is associated with a reduced risk of dementia.

The researchers linked health and pension databases of self-employed workers who were living and retired as of December 31, 2010. Workers had been retired on average for more than 12 years. Prevalence of dementia in this group was 2.65 percent.

Analyses showed that the risk of being diagnosed with dementia was lower for each year of working longer (i.e., higher age at retirement) (hazard ratio of dementia was 0.968 (95 percent Confidence Interval = [0.962-0.973]). Even after excluding workers who had dementia diagnosed within the 5 years following retirement, the results remained unchanged and highly significant (p<0.0001).

"Our data show strong evidence of a significant decrease in the risk of developing dementia associated with older age at retirement, in line with the 'use it or lose it' hypothesis," said Dufouil. "The patterns were even stronger when we focused on more recent birth cohorts."

"Professional activity may be an important determinant of intellectual stimulation and mental engagement, which are thought to be potentially protective against dementia," observed Dufouil. "As countries around the world respond to the aging of their populations, our results highlight the importance of maintaining high levels of cognitive and social stimulation throughout work and retired life, and they emphasize the need for policies to help older individuals achieve cognitive and social engagement.

The study was also coordinated by the International Longevity Center-France (Head: Prof. Francoise Forette).

Socioeconomic disparities may explain higher Alzheimer's risk among African Americans

Alzheimer's disease and other dementias have been shown to be higher among older blacks in the United States than older whites; however, risk factors that might account for this difference have not been extensively studied.

Note: According to the Alzheimer's Association 2013 Alzheimer's Disease Facts and Figures report, older African-Americans are about twice as likely to have Alzheimer's and other dementias as older whites, and Hispanics are about one and one-half times as likely to have Alzheimer's and other dementias as older whites.

Kristine Yaffe, M.D., of the University of California, San Francisco and the San Francisco VA Medical Center, and colleagues sought to determine if differences in dementia rates by race existed among a cohort of community dwelling elders and whether any differences observed could be explained by socioeconomic status (SES) indicators (income, financial adequacy, education and literacy) and health-related factors.

The scientists evaluated dementia risk among 3,075 black and white elders (mean age 74.1 years) participating in the ongoing prospective Health, Aging and Body Composition Study who were free of dementia at baseline.

During 12 years of follow-up, 18.7 percent of participants were determined to have developed dementia, based on prescribed medications, hospital records and cognitive decline. In this population, African-Americans were 1.5 times more likely to develop dementia than whites (21.9 percent vs. 16.4 percent). However, after adjusting for socioeconomic factors including education level, literacy, income and financial adequacy, the researchers found that the difference in risk was no longer statistically significant.

"Our findings suggest that differences in socioeconomic factors may, in large part, explain racial and ethnic disparities in dementia rates," said Yaffe. "Future studies that investigate these disparities should take a broad range of socioeconomic factors into account."

Yaffe suggested that more studies are needed "to explore the potential benefits of improving socioeconomic risk factors as a way of reducing dementia rates."

(Disclosure: Dr. Yaffe is co-chair of the AAIC 2013 Program Committee.)

About AAIC
The Alzheimer's Association International Conference (AAIC) is the world's largest conference of its kind, bringing together researchers from around the world to report and discuss groundbreaking research and information on the cause, diagnosis, treatment and prevention of Alzheimer's disease and related disorders.  As a part of the Alzheimer's Association's research program, AAIC serves as a catalyst for generating new knowledge about dementia and fostering a vital, collegial research community.

About the Alzheimer's Association
The Alzheimer's Association is the world's leading voluntary health organization in Alzheimer care, support and research. Our mission is to eliminate Alzheimer's disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer's. Visit www.alz.org or call 800.272.3900.

 

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
The Internet of Things will greatly expand the opportunities for data collection and new business models driven off of that data. In her session at @ThingsExpo, Esmeralda Swartz, CMO of MetraTech, discussed how for this to be effective you not only need to have infrastructure and operational models capable of utilizing this new phenomenon, but increasingly service providers will need to convince a skeptical public to participate. Get ready to show them the money!
DevOps is all about agility. However, you don't want to be on a high-speed bus to nowhere. The right DevOps approach controls velocity with a tight feedback loop that not only consists of operational data but also incorporates business context. With a business context in the decision making, the right business priorities are incorporated, which results in a higher value creation. In his session at DevOps Summit, Todd Rader, Solutions Architect at AppDynamics, discussed key monitoring techniques...
Want to enable self-service provisioning of application environments in minutes that mirror production? Can you automatically provide rich data with code-level detail back to the developers when issues occur in production? In his session at DevOps Summit, David Tesar, Microsoft Technical Evangelist on Microsoft Azure and DevOps, will discuss how to accomplish this and more utilizing technologies such as Microsoft Azure, Visual Studio online, and Application Insights in this demo-heavy session.
DevOps Summit, taking place Nov 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA, is co-located with 17th Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long developmen...
The 5th International DevOps Summit, co-located with 17th International Cloud Expo – being held November 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA – announces that its Call for Papers is open. Born out of proven success in agile development, cloud computing, and process automation, DevOps is a macro trend you cannot afford to miss. From showcase success stories from early adopters and web-scale businesses, DevOps is expanding to organizations of all sizes, including the...
SYS-CON Events announced today that MetraTech, now part of Ericsson, has been named “Silver Sponsor” of SYS-CON's 16th International Cloud Expo®, which will take place on June 9–11, 2015, at the Javits Center in New York, NY. Ericsson is the driving force behind the Networked Society- a world leader in communications infrastructure, software and services. Some 40% of the world’s mobile traffic runs through networks Ericsson has supplied, serving more than 2.5 billion subscribers.
Over the years, a variety of methodologies have emerged in order to overcome the challenges related to project constraints. The successful use of each methodology seems highly context-dependent. However, communication seems to be the common denominator of the many challenges that project management methodologies intend to resolve. In this respect, Information and Communication Technologies (ICTs) can be viewed as powerful tools for managing projects. Few research papers have focused on the way...
As the world moves from DevOps to NoOps, application deployment to the cloud ought to become a lot simpler. However, applications have been architected with a much tighter coupling than it needs to be which makes deployment in different environments and migration between them harder. The microservices architecture, which is the basis of many new age distributed systems such as OpenStack, Netflix and so on is at the heart of CloudFoundry – a complete developer-oriented Platform as a Service (PaaS...
In high-production environments where release cycles are measured in hours or minutes — not days or weeks — there's little room for mistakes and no room for confusion. Everyone has to understand what's happening, in real time, and have the means to do whatever is necessary to keep applications up and running optimally. DevOps is a high-stakes world, but done well, it delivers the agility and performance to significantly impact business competitiveness.
As cloud gives an opportunity to businesses to buy services externally – how is cloud impacting your customers? In his General Session at 15th Cloud Expo, Fabio Gori, Director of Worldwide Cloud Marketing at Cisco, provided answers to big questions: Do you see hybrid cloud as where the world is going? What benefits does it bring? And how does Cisco connect all of these clouds? He also discussed Intercloud and Cisco’s investment on it.
17th Cloud Expo, taking place Nov 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy. Meanwhile, 94% of enterprises a...
The 17th International Cloud Expo has announced that its Call for Papers is open. 17th International Cloud Expo, to be held November 3-5, 2015, at the Santa Clara Convention Center in Santa Clara, CA, brings together Cloud Computing, APM, APIs, Microservices, Security, Big Data, Internet of Things, DevOps and WebRTC to one location. With cloud computing driving a higher percentage of enterprise IT budgets every year, it becomes increasingly important to plant your flag in this fast-expanding bu...
There is no question that the cloud is where businesses want to host data. Until recently hypervisor virtualization was the most widely used method in cloud computing. Recently virtual containers have been gaining in popularity, and for good reason. In the debate between virtual machines and containers, the latter have been seen as the new kid on the block – and like other emerging technology have had some initial shortcomings. However, the container space has evolved drastically since coming on...
The Internet of Things is not new. Historically, smart businesses have used its basic concept of leveraging data to drive better decision making and have capitalized on those insights to realize additional revenue opportunities. So, what has changed to make the Internet of Things one of the hottest topics in tech? In his session at @ThingsExpo, Chris Gray, Director, Embedded and Internet of Things, discussed the underlying factors that are driving the economics of intelligent systems. Discover ...
Enterprises are fast realizing the importance of integrating SaaS/Cloud applications, API and on-premises data and processes, to unleash hidden value. This webinar explores how managers can use a Microservice-centric approach to aggressively tackle the unexpected new integration challenges posed by proliferation of cloud, mobile, social and big data projects. Industry analyst and SOA expert Jason Bloomberg will strip away the hype from microservices, and clearly identify their advantages and d...